A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors

2020 ◽  
Vol 38 (6) ◽  
pp. 1815-1825 ◽  
Author(s):  
Charlotte Lemech ◽  
Natasha Woodward ◽  
Nancy Chan ◽  
Joanne Mortimer ◽  
Louie Naumovski ◽  
...  
Cancer ◽  
2017 ◽  
Vol 123 (16) ◽  
pp. 3080-3087 ◽  
Author(s):  
Kathleen N. Moore ◽  
Hossein Borghaei ◽  
David M. O'Malley ◽  
Woondong Jeong ◽  
Shelly M. Seward ◽  
...  

2018 ◽  
Vol 36 (5) ◽  
pp. 836-847 ◽  
Author(s):  
Gentry T. King ◽  
Keith D. Eaton ◽  
Brandon R. Beagle ◽  
Christopher J. Zopf ◽  
Gilbert Y. Wong ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 2510-2510 ◽  
Author(s):  
John H. Strickler ◽  
John J. Nemunaitis ◽  
Colin D. Weekes ◽  
Ramesh K. Ramanathan ◽  
Eric Angevin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document